Member Info for hazrat

So 325 tonnes apparantly shipped to date. 50 tonnes in December, 75 tonnes in January leaving 200 tonnes for February and March. If the 325 is accurate, then the ramp up of production has indeed been slow and power rather than weather is cited as the cause in the news report. Long way to go to get to the 520 tonnes a month now required from April onwards to reach the target of 5,000. Having said that, the 5,000 tonnes a year is a run rate target rather than an actual in year production target. I read that as meaning mission accomplished if they are shipping just over 400 tonnes a month by December. Should be achievable as a long way to go.

Today's dip is understandable. People sitting on big profits in a high risk company had an excuse to bank that profit. Very short term in my opinion because as said before, the value is in the drilling not short term production.

Great dividend policy, becoming vertically integrated and more efficient. Not sure how this is priced in with a terribly low PE. Will buy more. Cracking company,

given a pretty positive RNS today.

The timeline has been clearly set out by the company. Med licensing deal announcement before the end of Q2. Phase 3 trials to start around the same time. Results of trial expected next year. So clarity around the timeline is not the issue. Passing phase 3 trials and securing a deal are the problems. I will hold until the end of Q2. If no deal is signed by then, i am off.

Phew! When I saw a holding RNS was out I thought I was about to be proved wrong in record time!

Shakey, I would be suprised if they started to take profit now. Generally the model for investing in small high risk, high reward companies like this is that you invest a small amount in lots of them and ride the winners to cover the losses in the majority of the portfolio and so make a profit overall. Exiting now would scupper this strategy. They need to win big here to make it work.

Quarterly updates generally seem to come on 10th of the month so should be one in a few days. I expect it to be very positive

That is a fair point Tiger, I am just a bit more cautious than you because I don't know how much value there is the veins being mined. There probably is enough to justify at �40m market cap but until it's proved up I will remain cautious. If I don't I will get carried away and put too much money in.

Must have been a very long time. Hasn't changed for nearly a year.

All speculative at the moment. Been here since 11p days but average 15p due to late buy ins. Hopefully 2 separate tranches if news this month. 1 being the quarterly update which finally gives some financials, though you can piece it together from year end results. Then the drilling results to round it off. Still binary. Good results = multiples. Poor results = lose it all. Quite exciting recently

I don't. My hope is it is misplaced concern over the departure of the CEO. My fear is a leak of bad news prior to the pre close announcement on 5th April. However, if the company new bad news which would affect the share price, they have to announce and so don't think it can be that.

Even bigger buys coming in today ahead of HY results

Can only think it is the same sentiment that is holding back Lloyds - concern over the UK economy and brexit, concern over increasing debt levels etc. Frustrating but patience is needed, something often lacking in AIM.

Apologies if posted already. Both GSK and RB pulled out of buying viagra connect, an otc version of viagra, last week. I wonder if that is because they have their focus on a new product?

RB cancelled previous arrangements. Things have changed but no evidence to support them being interested again.

Everyone. Things look very positive here. The timeliness isn't slipping and the potential is huge. Of course the sp will fluctuate but the recent rise and dip was based on the hope of news with the results which wasn't founded on anything. Companies have to release material news as soon as possible and so expecting results and news to coincide is folly. Things look better and better. When at Deloitte I worked on IPO'S of pharma companies. Quite a few dual listed or listed in the UK when small and then moved to NASDAQ as they grew because the US market for pharma is so much greater. A company this close to completing it's trials would be worth hundreds of millions if US listed.

No one knows. The price is likely rising because of speculation in advance of drill results. I expect a plateau, followed by a dip before a reaction to the drill results. I think they will be good and so am holding. I am prepared to lose all if they are below expectation because that is the nature of the game. On the flip side, I will enjoy the rewards if forthcoming and could be spectacular. In regard to comments that a DCF is not currently possible, I disagree. As I have previously posted, RBW has released enough info to determine cost of production, SG&A and sales price etc, so a rough DCF is possible on a scenario basis. However, I do agree that it is all meaningless until a Jorc is determined so we know what we are aiming at. The offstage arrangement, while a bit onerous at 70% does have many advantages. We don't pay shipping costs, we don't carry credit risk and we don't have to find a buyer. For a company of this size the benefits outweigh the costs and so I can see why they took the plunge. If the resource is a large as hoped then 10k tonnes a year on this deal is a good grounding with any additional sales having a material upside to cash generation.

Correction, meant to say they pay 30% of the market price.

TK pay RBW 70% of the market price, they don't take 75% of the profit.